Texas A&M Veterinary Medical Diagnostic Laboratory

Texas A&M Veterinary Medical Diagnostic Laboratory, operating as a division of the Texas A&M University System and doing business as Texas A&M Veterinary Medical Diagnostic Laboratory System, is a state government entity and 1862 land grant college that delivers high-consequence animal disease diagnostic testing to the federal government as a prime contractor (98% of awards) under full-and-open procurements with no socioeconomic set-aside designations. The laboratory operates testing facilities in College Station, Texas and Ames, Iowa, and serves as a core member of the National Animal Health Laboratory Network (NAHLN), providing comprehensive veterinary diagnostic and analytical services to support federal animal health surveillance and emergency response.

TVMDL's customer footprint is highly concentrated within the Department of Agriculture. USDA APHIS Veterinary Services dominates both volume and dollars, accounting for 73 awards valued at $22.9 million combined potential value (78% of recent contract awards across the top five customer segments). APHIS Marketing and Regulatory Programs Business Services placed 22 awards worth $21.4 million. The National Institute of Food and Agriculture awarded 11 grants. Across 187 total awards in the source data, distinct customer agencies number eleven, but the top five USDA APHIS divisions account for approximately 97% of combined potential value, with veterinary services and marketing/regulatory programs anchoring the dollars.

TVMDL's prime contract work flows through a cornerstone single-award Indefinite Delivery Contract (12639521D0077) with APHIS Veterinary Services, valued at $20 million and awarded September 20, 2021. This IDC has generated 33 task orders totaling $2.2 million in combined potential value across diagnostic testing for highly pathogenic avian influenza (HPAI), low pathogenic avian influenza (LPAI), classical swine fever, African swine fever, scrapie, anthrax, rabies, New World screwworm, foreign animal disease screening, and antimicrobial resistance and susceptibility testing. Recent representative delivery orders include a $500,000 July 2026 award for HPAI end-user testing, a $147,000 July 2026 order for Texas Newcastle virus disease (NWS) testing, a $300,000 March 2025 delivery order for HPAI testing from the Ames facility, and a $100,000 December 2025 award for HPAI diagnostic testing. TVMDL also holds multiple blanket purchase agreements with APHIS, including AG6395B100019 (23 task orders, $823 thousand combined potential value), AG6395B130098 (14 task orders, $880 thousand), and AG6395B070049 (9 task orders, $15 thousand).

TVMDL operates as a prime recipient on a growing portfolio of federal grants focused on laboratory infrastructure, workforce development, and diagnostic capability enhancement. The Department of Agriculture Animal and Plant Health Inspection Service awarded a $399,834 cooperative agreement in February 2026 under CFDA 10.025 (Plant and Animal Disease, Pest Control, and Animal Care) to enhance surge-testing capacity for Influenza A Virus detection by validating real-time RT-PCR assays with reduced reaction volumes, evaluating enzyme and buffer kit chemistries, implementing robotic dispensing automation, and delivering technology transfer to NAHLN and other stakeholder laboratories. Prior grants from APHIS include a $199,984 cooperative agreement (July 2024 through June 2025) to develop a toolkit for improving sample submission and accessioning workflows during disease outbreaks, and annual infrastructure support cooperative agreements totaling $250,000 per year for quality management systems, laboratory information management systems, staffing expertise, and equipment enhancement (most recently June 2024 through May 2025). The National Institute of Food and Agriculture awarded a $250,000 cooperative agreement in September 2023 under CFDA 10.304 (Food and Agriculture Defense Initiative) to support NAHLN infrastructure, staff training and proficiency testing for high-consequence disease response, and expansion of HL7 messaging capabilities for electronic data reporting between NAHLN labs and state animal health officials. TVMDL also functions as a sub-recipient on a Texas Parks and Wildlife Department cooperative agreement (awarded November 2025) for chronic wasting disease sample testing and analysis, and on prior TPWD awards for big game research and coordination.

Award activity has accelerated from five contracts in 2022 to nine in 2026, with firm fixed-price delivery orders ranging from $1,100 to $500,000 across the active portfolio. Twelve awards with ultimate completion dates in the next twenty-four months carry combined potential value of $792 thousand, representing modest near-term recompete exposure relative to the cornerstone IDC's stable $20 million ceiling. TVMDL holds no subcontract awards in the source data; the 2% sub-award representation consists of three grants received as a sub-recipient from state-level grantees. The laboratory's award concentration by NAICS spans Testing Laboratories and Services (73 awards) and Veterinary Services (62 awards), with reference laboratory testing and veterinary/animal care support defining the PSC footprint.